Active Not RecruitingNCT04685590
Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study
PHASE2 · 48 planned enrolment
- Countries listed
- 2
- Registry update
- April 1, 2026
immortal.lifeTrial registrations containing the exact intervention label Placebo capsules.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 48 planned enrolment
Phase not reported · 60 planned enrolment